Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT01318473 Completed - Cancer Clinical Trials

The Use of the ActiSightâ„¢ Needle Guidance System in Patients Undergoing CT-Guided With Lesions Smaller Than 15 mm

ActiSight
Start date: June 2009
Phase: Phase 4
Study type: Interventional

This will be a prospective, single-arm, single-center, open-label study to evaluate the use of the ActiSightâ„¢ Needle Guidance System in patients with lung lesions smaller than 15 mm undergoing CT-guided percutaneous chest aspiration. Target location will be in the chest area; the procedure will be performed by a trained physician.

NCT ID: NCT01317355 Completed - Cancer Clinical Trials

Multiple Symptoms in Cancer Patients a Cross Sectional Multi Center Study

ProKID
Start date: June 2010
Phase: N/A
Study type: Observational

This study will assess the occurrence of multiple symptoms in cancer patients of 5 German university hospitals. Primary goal of the study is to assess the prevalence of multiple symptoms and related symptom clusters (e.g. pain, fatigue and sleep disorder).

NCT ID: NCT01316744 Recruiting - Cancer Clinical Trials

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Start date: April 2009
Phase: Phase 3
Study type: Interventional

RATIONALE: Ketamine hydrochloride may lessen neuropathic pain in patients with cancer. It is not yet known whether ketamine hydrochloride given together with the best pain management is more effective than a placebo given together with the best pain management in treating neuropathic pain in patients with cancer. PURPOSE: This randomized phase III trial is studying ketamine hydrochloride given together with the best pain management to see how well it works compared with giving a placebo together with the best pain management in treating cancer patients with neuropathic pain.

NCT ID: NCT01313780 Completed - Cancer Clinical Trials

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

TOP
Start date: May 2011
Phase: Phase 4
Study type: Interventional

Objectives: To prove non-inferiority of Targin compared to Oxycontin in terms of change of pain intensity 1. Primary objective: Change of pain intensity (NRS 0-10) score (average pain over 24 hours obtained each evening) within 4 weeks 2. Secondary objectives: Bowel Habit (worsening/no change/improving), Total dose and frequency of rescue medication, Quality of Life (QOL; EORTC QLQ-C30), Duration to need of laxative use and Adverse events

NCT ID: NCT01311388 Active, not recruiting - Cancer Clinical Trials

Construction of the "Patient-Centered"Molecular Pathology Diagnostic Center

Start date: August 2010
Phase: N/A
Study type: Observational

The investigators want to achieve the goal of diagnosis in early phase, accurate treatment and existence for a long period in order to screen in early phase, diagnose in clinical trial, choose treatment and evaluate prognosis of cancers by establishing molecular pathology tools.

NCT ID: NCT01310829 Withdrawn - Cancer Clinical Trials

Virtual Reality Intervention in Cancer Genetics

Start date: February 2011
Phase: N/A
Study type: Observational

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel patients regarding cancer genetics.

NCT ID: NCT01309815 Completed - Cancer Clinical Trials

Existential Issues in Elderly People With Cancer

Start date: February 2011
Phase: N/A
Study type: Observational

The purpose is to describe, interpret and provide a detailed understanding of what it means to be elderly people with cancer who receive treatment in specialized health care. Focus is especially put on the content and expression of existential issues and the importance of spirituality for the patient´s life story and medical story.

NCT ID: NCT01305447 Completed - Cancer Clinical Trials

Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention

Start date: October 2009
Phase: Phase 2
Study type: Interventional

Adult female smokers will participate in an exercise-aided smoking cessation program, and will then be randomized into one of four cessation maintenance conditions: (a) Exercise Maintenance only (b) Exercise Maintenance + Relapse Prevention Booklets(c) Relapse Prevention Booklets + Contact and (d) Contact Control. Primary follow-up outcome is smoking behaviour. Secondary outcomes include exercise behaviour, Physiological measures (body composition (Dual-emission X-ray absorptiometry; DXA), vascular health (stiffness, endothelial function, carotid plaque volume), physical fitness), and Psychological measures (self-regulatory cognitions related to exercise adherence [exercise, scheduling, barrier, relapse, and concurrent self-regulatory self-efficacy]). The hypotheses detailed below are specific to the randomization of participants into the following 4 groups: 1. Exercise Maintenance only 2. Exercise Maintenance + Relapse Prevention Booklets 3. Relapse Prevention Booklets + Contact 4. Contact Control Hypothesis 1: Compared to quitters in the contact control condition, quitters exposed to a home-based lifestyle exercise maintenance intervention (Exercise Maintenance only and Exercise Maintenance + Relapse Prevention Booklets) will demonstrate significantly greater exercise adherence and fitness levels, as well as significantly less weight gain and smoking relapse rates following exercise-aided smoking cessation program termination. Hypothesis 2: Compared to quitters in the contact control condition, quitters exposed to relapse information only (Relapse Prevention Booklets + Contact) will experience significantly less smoking relapse following exercise-aided smoking cessation program termination. Due to the novelty and exploratory nature of the respective prevention programs, no hypotheses are specified with respect to which prevention program (exercise maintenance or relapse prevention information) will be superior to the other, or whether the additive benefits (i.e., exercise maintenance plus relapse prevention information) will be superior to one prevention program alone.

NCT ID: NCT01304680 Recruiting - Cancer Clinical Trials

Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock

Start date: January 2011
Phase: N/A
Study type: Observational

Retrospective study to evaluate the characteristics of patients and of fluid resuscitation during intensive care unit hospitalization of patients under septic chock.

NCT ID: NCT01304446 Completed - Cancer Clinical Trials

Enteral Nutrition in Cancer Patients

Start date: n/a
Phase: Phase 4
Study type: Interventional

CONTEXT AND OBJECTIVE: Tumor and its therapy have adverse effects on the nutritional status of cancer patients, leading to nutritional support. The aim was to study enteral nutrition indications, as well as its compliance and the impact on nutritional status. DESIGN AND SETTING: Clinical trial, IOP, Unifesp-EPM. METHODS: Patients older than 1 year followed during anticancer therapy were included from January 2002 to January 2004. They received industrialized oral supplementation - Nutren 1.0 or Jr (IOS) and were followed on a weekly basis and reevaluated on weeks 3, 8 and 12: at these times, if inadequate outcome was observed, tube feeding with the same supplement (TFR) was indicated.